{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:17:45Z","timestamp":1778887065002,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Mechanism of TRIM44 regulating the progression and development of multiple myeloma through ZEB1","award":["2022NYFYFG015"],"award-info":[{"award-number":["2022NYFYFG015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01933-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:35:57Z","timestamp":1740753357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TRIM44 facilitates aggressive behaviors in multiple myeloma through promoting ZEB1 deubiquitination"],"prefix":"10.1007","volume":"16","author":[{"given":"Hui","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"1","key":"1933_CR1","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1038\/s41467-022-34654-2","volume":"13","author":"A Vdovin","year":"2022","unstructured":"Vdovin A, Jelinek T, Zihala D, Sevcikova T, Durech M, Sahinbegovic H, et al. The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma. Nat Commun. 2022;13(1):6820.","journal-title":"Nat Commun"},{"issue":"12","key":"1933_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/ijc.33762","volume":"149","author":"K Hemminki","year":"2021","unstructured":"Hemminki K, Forsti A, Houlston R, Sud A. Epidemiology, genetics and treatment of multiple myeloma and precursor diseases. Int J Cancer. 2021;149(12):1980\u201396.","journal-title":"Int J Cancer"},{"issue":"1","key":"1933_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19(1):1\u2013146.","journal-title":"Mol Cancer"},{"issue":"1","key":"1933_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40164-022-00322-w","volume":"11","author":"N Huang","year":"2022","unstructured":"Huang N, Sun X, Li P, Liu X, Zhang X, Chen Q, et al. TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Exp Hematol Oncol. 2022;11(1):75.","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"1933_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/15548627.2021.1956105","volume":"18","author":"L Lyu","year":"2022","unstructured":"Lyu L, Chen Z, McCarty N. TRIM44 links the UPS to SQSTM1\/p62-dependent aggrephagy and removing misfolded proteins. Autophagy. 2022;18(4):783\u201398.","journal-title":"Autophagy"},{"key":"1933_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.biopha.2017.09.132","volume":"96","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Liu Y, Ma M, Chang L. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt\/beta-catenin signaling pathway. Biomed Pharmacother. 2017;96:98\u2013103.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1933_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-019-1138-7","volume":"38","author":"C Wei","year":"2019","unstructured":"Wei C, Wang L, Zhu M, Deng X, Wang D, Zhang S, et al. TRIM44 activates the AKT\/mTOR signal pathway to induce melanoma progression by stabilizing TLR4. J Exp Clin Cancer Res. 2019;38(1):137.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1933_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10147-014-0752-9","volume":"20","author":"Q Luo","year":"2015","unstructured":"Luo Q, Lin H, Ye X, Huang J, Lu S, Xu L. Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-kappaB signaling pathway. Int J Clin Oncol. 2015;20(3):508\u201317.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"1933_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41375-018-0222-x","volume":"33","author":"Z Chen","year":"2019","unstructured":"Chen Z, Lin TC, Bi X, Lu G, Dawson BC, Miranda R, et al. TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1alpha stabilization. Leukemia. 2019;33(2):469\u201386.","journal-title":"Leukemia"},{"issue":"1","key":"1933_CR10","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41467-022-29723-5","volume":"13","author":"N Mohammadi Ghahhari","year":"2022","unstructured":"Mohammadi Ghahhari N, Sznurkowska MK, Hulo N, Bernasconi L, Aceto N, Picard D. Cooperative interaction between ER\u03b1 and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis. Nat Commun. 2022;13(1):2104.","journal-title":"Nat Commun"},{"issue":"1","key":"1933_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12967-020-02240-z","volume":"18","author":"H Wu","year":"2020","unstructured":"Wu H, Zhong H, Li G, Shen J, Ye Q, Zhang M, et al. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer. J Transl Med. 2020;18(1):51.","journal-title":"J Transl Med"},{"key":"1933_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106311","volume":"182","author":"M Sadrkhanloo","year":"2022","unstructured":"Sadrkhanloo M, Entezari M, Orouei S, Ghollasi M, Fathi N, Rezaei S, et al. STAT3-EMT axis in tumors: modulation of cancer metastasis, stemness and therapy response. Pharmacol Res. 2022;182: 106311.","journal-title":"Pharmacol Res"},{"issue":"8","key":"1933_CR13","first-page":"543","volume":"64","author":"P Sieben","year":"1987","unstructured":"Sieben P. Africa immunization year 1986 (Botswana experience). East Afr Med J. 1987;64(8):543\u201350.","journal-title":"East Afr Med J"},{"issue":"1","key":"1933_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41392-020-0118-x","volume":"5","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Li J, Ou Y, Yang G, Deng K, Wang Q, et al. CDK4\/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism. Signal Transduct Target Ther. 2020;5(1):25.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1933_CR15","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s11010-020-04036-7","volume":"476","author":"L Cheng","year":"2021","unstructured":"Cheng L, Zhou M, Gu Y, Chen L, Wang Y. ZEB1: new advances in fibrosis and cancer. Mol Cell Biochem. 2021;476(4):1643\u201350.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1933_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12885-020-07014-w","volume":"20","author":"G Xiao","year":"2020","unstructured":"Xiao G, Yang Q, Bao Z, Mao H, Zhang Y, Lin S. Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies: a meta-analysis. BMC Cancer. 2020;20(1):525.","journal-title":"BMC Cancer"},{"issue":"6","key":"1933_CR17","first-page":"3152","volume":"24","author":"X Ji","year":"2020","unstructured":"Ji X, Tao R, Sun L, Xu X, Ling W. Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT\/mTOR pathway in non-small-cell lung cancer. Eur Rev Med Pharmacol. 2020;24(6):3152.","journal-title":"Eur Rev Med Pharmacol"},{"issue":"10","key":"1933_CR18","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1111\/cas.13762","volume":"109","author":"D Xiong","year":"2018","unstructured":"Xiong D, Jin C, Ye X, Qiu B, Jianjun X, Zhu S, et al. TRIM44 promotes human esophageal cancer progression via the AKT\/mTOR pathway. Cancer Sci. 2018;109(10):3080\u201392.","journal-title":"Cancer Sci"},{"issue":"11","key":"1933_CR19","doi-asserted-by":"publisher","first-page":"14615","DOI":"10.1007\/s13277-016-5316-3","volume":"37","author":"X Zhu","year":"2016","unstructured":"Zhu X, Wu Y, Miao X, Li C, Yin H, Yang S, et al. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Tumor Biol. 2016;37(11):14615\u201328.","journal-title":"Tumor Biol"},{"issue":"17","key":"1933_CR20","first-page":"1431","volume":"13","author":"T Vu","year":"2024","unstructured":"Vu T, Wang Y, Fowler A, Simieou A, McCarty N. TRIM44, a novel prognostic marker, supports the survival of proteasome-resistant multiple myeloma cells. Cells (Basel, Switzerland). 2024;13(17):1431.","journal-title":"Cells (Basel, Switzerland)"},{"issue":"2","key":"1933_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28(2):591\u2013605.","journal-title":"Cell Death Differ"},{"issue":"5","key":"1933_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H, et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 2017;19(5):518\u201329.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"1933_CR23","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1053\/j.gastro.2020.12.077","volume":"160","author":"M Liu","year":"2021","unstructured":"Liu M, Zhang Y, Yang J, Zhan H, Zhou Z, Jiang Y, et al. Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer. Gastroenterology. 2021;160(5):1771\u201383.","journal-title":"Gastroenterology"},{"issue":"1","key":"1933_CR24","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1038\/s41467-019-12832-z","volume":"10","author":"R Manshouri","year":"2019","unstructured":"Manshouri R, Coyaud E, Kundu ST, Peng DH, Stratton SA, Alton K, et al. ZEB1\/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer. Nat Commun. 2019;10(1):5115\u201325.","journal-title":"Nat Commun"},{"issue":"24","key":"1933_CR25","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1038\/onc.2010.102","volume":"29","author":"E Sanchez-Tillo","year":"2010","unstructured":"Sanchez-Tillo E, Lazaro A, Torrent R, Cuatrecasas M, Vaquero EC, Castells A, et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI\/SNF chromatin-remodeling protein BRG1. Oncogene. 2010;29(24):3490\u2013500.","journal-title":"Oncogene"},{"issue":"11","key":"1933_CR26","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1073\/pnas.1918167117","volume":"117","author":"T Na","year":"2020","unstructured":"Na T, Schecterson L, Mendonsa AM, Gumbiner BM. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci PNAS. 2020;117(11):5931\u20137.","journal-title":"Proc Natl Acad Sci PNAS"},{"key":"1933_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 2018;13:395\u2013412.","journal-title":"Annu Rev Pathol"},{"issue":"8","key":"1933_CR28","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/s41418-021-00754-7","volume":"28","author":"X Li","year":"2021","unstructured":"Li X, Yuan J, Song C, Lei Y, Xu J, Zhang G, et al. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma. Cell Death Differ. 2021;28(8):2315\u201332.","journal-title":"Cell Death Differ"},{"issue":"6","key":"1933_CR29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1158\/1541-7786.MCR-22-0552","volume":"21","author":"L Sun","year":"2023","unstructured":"Sun L, Yu J, Guinney J, Qin B, Sinicrope FA. USP10 regulates ZEB1 ubiquitination and protein stability to inhibit ZEB1-mediated colorectal cancer metastasis. Mol Cancer Res. 2023;21(6):578\u201390.","journal-title":"Mol Cancer Res"},{"issue":"3","key":"1933_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.prp.2015.12.011","volume":"212","author":"JZ Yang","year":"2016","unstructured":"Yang JZ, Lian WG, Sun LX, Qi DW, Ding Y, Zhang XH. High nuclear expression of Twist1 in the skeletal extramedullary disease of myeloma patients predicts inferior survival. Pathol Res Pract. 2016;212(3):210\u20136.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"1933_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s13402-022-00759-5","volume":"46","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wu X, Sun Y, Chu Y, Liu F, Chen C. TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling. Cell Oncol (Dordr). 2023;46(2):423\u201335.","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"1933_CR32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.4149\/neo_2021_201128N1285","volume":"68","author":"X Yu","year":"2021","unstructured":"Yu X, Yuan J, Ye H, Yi K, Qie M, Hou M. TRIM44 facilitates ovarian cancer proliferation, migration, and invasion by inhibiting FRK. Neoplasma. 2021;68(4):751.","journal-title":"Neoplasma"},{"key":"1933_CR33","doi-asserted-by":"publisher","first-page":"10693","DOI":"10.2147\/OTT.S228637","volume":"12","author":"CG Li","year":"2019","unstructured":"Li CG, Hu H, Yang XJ, Huang CQ, Yu XQ. TRIM44 promotes colorectal cancer proliferation, migration, and invasion through the Akt\/mTOR signaling pathway. Oncol Targets Ther. 2019;12:10693\u2013701.","journal-title":"Oncol Targets Ther"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01933-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01933-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01933-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:36:03Z","timestamp":1740753363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01933-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1933"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01933-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Affiliated Hospital of Inner Mongolia Medical University. All animal experiments should comply with the Ethics Committee of Affiliated Hospital of Inner Mongolia Medical University that approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}